Possible tumour marker found for the development of hepatocellular carcinoma

Cancer cells leave an "imprint" on natural killer cells

19-Mar-2024 - A research team at the MHH is comparing changes in natural killer cells of the innate immune defence system in chronic hepatitis C sufferers as a risk factor for the later development of hepatocellular carcinoma (HCC). Hepatocellular carcinoma (HCC) is a malignant liver tumour that develops from ...

Infectious agent offers protection against liver cancer

Vaccine proves safe and effective against liver fibrosis and liver cancer

22-Feb-2022 - Liver cancer is the third most common cause of cancer-related deaths worldwide. So far, the treatment options for two types of liver cancer, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), have been inadequate, while the number of new cases has been rising. A study by researchers at ...

Sensitive new assay detects hepatitis B infection in single liver cells and serum

13-Apr-2018 - Chronic hepatitis B virus (HBV) can progress to cirrhosis and hepatocellular carcinoma (HCC). A study describes a new HBV assay that offers advantages over currently used methods because it has the capability to detect closed circular DNA (cccDNA) in serum, single cells, and preserved tissue ...

Newly discovered protein prevents undisturbed proliferation of cancer cells

23-Mar-2018 - An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can ...

Micron-sized hydrogel cubes show highly efficient delivery of a potent anti-cancer drug

30-Jun-2017 - Many potent anti-cancer drugs have major drawbacks -- they fail to mix with water, which means they will have a limited solubility in blood, and they lack selectivity to cancer cells. Researchers at the University of Alabama at Birmingham and Texas Tech University Health Sciences Center have ...

Liver tumor growth in mice slowed with new chemo-immunotherapy treatment

02-Mar-2017 - Hepatocellular carcinoma is the most common form of liver cancer, but treatment options are limited and many patients are diagnosed in late stages when the disease can't be treated. Now, University of Missouri School of Medicine researchers have developed a new treatment that combines ...

Targeted treatment for liver cancer under way

25-May-2016 - Researchers at the University of Eastern Finland and Eberhard Karls Universität Tübingen have discovered a new molecular mechanism that can be used to inhibit the growth of hepatocellular carcinoma, which is the most common liver cancer. The study found that mouse and human liver cancer in which ...

Genetic Variant Linked to Development of Liver Cancer in Hepatitis C Virus Carriers

06-Jul-2011 - A genome-wide study by researchers at the RIKEN Center for Genomic Medicine, Hiroshima University Hospital and Sapporo-Kosei General Hospital has identified a genetic variant associated with the development of liver cancer in chronic hepatitis C virus carriers. The findings are based on a study ...

M. D. Anderson examines use of toad venom in cancer treatment

Phase I study shows the traditional Chinese medicine is well-tolerated

28-Sep-2009 - Huachansu, a Chinese medicine that comes from the dried venom secreted by the skin glands of toads, has tolerable toxicity levels, even at doses eight times those normally administered, and may slow disease progression in some cancer patients, say researchers from The University of Texas M. D. ...

Amorfix and BioMosaics collaborate to develop a blood test for liver cancer

27-Apr-2009 - Amorfix Life Sciences Ltd. and BioMosaics Inc. announced a collaboration to develop and commercialize a blood-based assay for early detection of hepatocellular carcinoma (HCC) or primary liver cancer. This effort is possible due to an "Intellectual Property Development and Commercialization ...